Real-world outcomes of mosunetuzumab use in relapsed/refractory indolent lymphomas: a CUBIC consortium analysis

Blood Neoplasia · Elsevier

Аннотация

Publication date: November 2026 Source: Blood Neoplasia, Volume 3, Issue 4 Author(s): Andrew P. Jallouk, Lorenzo Falchi, Ayushi Chauhan, Geoffrey Shouse, Swetha K. Thiruvengadam, Yazeed Sawalha, Sonia Godbole, Ajay Major, Reid W. Merryman, Shakthi T. Bhaskar, Allison M. Bock, Mehdi Hamadani, Amy Ayers, Omnia Farahat, Narendranath Epperla, Jennifer L. Crombie, Steven Bair, Mathew A. Lunning, Alex F. Herrera, Christopher R. Flowers

Читать у издателя →

Похожие статьи